Dengue fever is one of the fastest-spreading mosquito-borne viral infections globally, affecting millions annually across tropical and subtropical regions. With four distinct serotypes circulating simultaneously, accurate detection alone is not sufficient. Serotype-level identification plays a critical role in patient management, as secondary infection with a different serotype significantly elevates the risk of life-threatening complications including Dengue Hemorrhagic Fever and Dengue Shock Syndrome. Antibody-based tests are unreliable in the early acute phase, creating a diagnostic gap where molecular testing is essential.
The DENGUE-Q Real-Time PCR Kit from Genes2Me delivers simultaneous detection and serotyping of all four dengue virus serotypes in a single workflow. It detects viral RNA directly from whole blood, serum, or plasma during the acute phase, before antibody response develops, providing the earliest and most reliable window for clinical intervention.
Genes2Me is a CE Marked molecular diagnostics company trusted by clinical laboratories across global markets. The DENGUE-Q Real-Time PCR Kit meets European conformity standards for in vitro diagnostic devices, validated to international benchmarks for accuracy, reliability, and safety.
The DENGUE-Q kit uses a two-tube multiplex real-time RT-PCR format with fluorescently labelled TaqMan probes. DENV-1 and DENV-2 are detected in the FAM channel, while DENV-3 and DENV-4 are detected in the Texas Red channel. An internal control is monitored in the HEX channel in every reaction, preventing false negatives due to PCR inhibition or poor sample quality. Ready-to-use reagents including primer and probe mixes, reaction buffer, positive control, and qRT-PCR master mix are all supplied for a streamlined, contamination-free workflow.
All four dengue serotypes co-circulate in endemic regions and produce clinically indistinguishable presentations. Without serotype-level identification, clinicians cannot assess secondary infection risk, epidemiologists cannot track outbreak dynamics, and public health teams cannot implement targeted vector control measures. A multiplex assay with built-in internal controls detects and differentiates all four serotypes in a single workflow, delivering actionable results that a single-target or antibody-based test cannot provide.
A two-tube multiplex format identifies DENV-1, DENV-2, DENV-3, and DENV-4 in a single workflow, supporting clinical correlation and epidemiological studies without additional testing.
Detects dengue RNA before antibody response develops, enabling diagnosis in the critical early window when clinical intervention is most effective.
Reliable detection even at very low viral loads, ensuring accurate identification across all stages of acute dengue infection.
HEX channel monitors PCR inhibition and sample quality in each tube, preventing false negatives and ensuring result integrity.
Primer and probe mixes, reaction buffer, positive control, and qRT-PCR master mix are all supplied, supporting a streamlined and contamination-free workflow.
Accepts whole blood, serum, and plasma, offering flexibility to suit different clinical collection and processing protocols.
| Commercial Name | Old Cat No. | New Cat No. | Pack Size |
|---|---|---|---|
| Dengue-Q Real-Time PCR Kit | G610002-1 | 50 Tests |
Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.
© 2025 Genes2me. All rights reserved.
